208 related articles for article (PubMed ID: 17671179)
1. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
2. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA
Oncogene; 2001 Jan; 20(4):451-60. PubMed ID: 11313976
[TBL] [Abstract][Full Text] [Related]
4. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
5. Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.
Wu C; Amini-Nik S; Nadesan P; Stanford WL; Alman BA
Cancer Res; 2010 Oct; 70(19):7690-8. PubMed ID: 20841474
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor).
Fen Li C; Kandel C; Baliko F; Nadesan P; Brünner N; Alman BA
Oncogene; 2005 Feb; 24(9):1615-24. PubMed ID: 15674349
[TBL] [Abstract][Full Text] [Related]
7. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
Yang JL; Wang J; Zhou XY; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
[TBL] [Abstract][Full Text] [Related]
8. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.
Kong Y; Poon R; Nadesan P; Di Muccio T; Fodde R; Khokha R; Alman BA
Cancer Res; 2004 Aug; 64(16):5795-803. PubMed ID: 15313922
[TBL] [Abstract][Full Text] [Related]
10. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).
Tejpar S; Li C; Yu C; Poon R; Denys H; Sciot R; Van Cutsem E; Cassiman JJ; Alman BA
Br J Cancer; 2001 Jul; 85(1):98-101. PubMed ID: 11437409
[TBL] [Abstract][Full Text] [Related]
11. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
12. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
13. Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.
Ghanbari-Azarnier R; Sato S; Wei Q; Al-Jazrawe M; Alman BA
Neoplasia; 2013 Jul; 15(7):712-9. PubMed ID: 23814483
[TBL] [Abstract][Full Text] [Related]
14. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
15. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).
Hong H; Nadesan P; Poon R; Alman BA
Br J Cancer; 2011 Apr; 104(9):1452-8. PubMed ID: 21468052
[TBL] [Abstract][Full Text] [Related]
16. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
[TBL] [Abstract][Full Text] [Related]
17. Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling.
Mizutani T; Tsuji K; Ebihara Y; Taki S; Ohba Y; Taniguchi T; Honda K
Exp Hematol; 2008 Mar; 36(3):255-64. PubMed ID: 18207304
[TBL] [Abstract][Full Text] [Related]
18. Cytokines associated with the pathophysiology of aggressive fibromatosis.
Mills BG; Frausto A; Brien E
J Orthop Res; 2000 Jul; 18(4):655-62. PubMed ID: 11052503
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
